Research

Cancer-linked mutations in the brain cells may drive Alzheimer’s disease

by

The Unexpected Link Between Alzheimer’s and Blood Cancers For decades, Alzheimer’s disease has been viewed primarily through the lens of protein clumps and cognitive decline. However, groundbreaking research from Boston Children’s Hospital is shifting this paradigm. Scientists have discovered that the brain’s resident immune cells, known as microglia, accumulate mutations in specific cancer-driving genes as … Read more

New research calls for improved pediatric burn care infrastructure nationwide

by

The Critical Gap in Pediatric Burn Care The landscape of burn treatment in the United States is currently an uneven network. While many acute care hospitals provide basic burn services, there is a significant shortage of specialized facilities equipped to handle the unique needs of children. According to a review paper co-authored by Dr. James … Read more

Oral bacteria can reveal your true biological age and health risks

by

Beyond the Calendar: The Rise of Biological Age Tracking For decades, we have relied on chronological age—the number of birthdays we’ve celebrated—to estimate our health risks. However, medical science is shifting toward “biological age,” a more accurate reflection of how our bodies are actually aging on a cellular and systemic level. While gut-based aging clocks … Read more

High-fat, low-carbohydrate diet may improve beta-cell function in patients with type 2 diabetes

by

The Shift Toward Beta-Cell Recovery in Type 2 Diabetes For years, the approach to managing type 2 diabetes has focused primarily on controlling blood sugar levels through medication and weight loss. However, emerging research suggests a pivot toward a more fundamental goal: recovering the function of the pancreas’s beta-cells. Beta-cells are the endocrine cells responsible … Read more

High immune cell ratios may predict future Alzheimer’s disease risk

by

The New Frontier of Early Dementia Detection For decades, the challenge with Alzheimer’s disease and related dementias has been the “silent window”—the period where the brain is changing, but the patient shows no outward signs of cognitive impairment. A groundbreaking shift is occurring in how we identify this window, moving away from waiting for memory … Read more

Alzheimer’s monoclonal antibodies fail to deliver meaningful results

by

The Amyloid Paradox: Clearing Plaques vs. Restoring Memory For years, the scientific community focused on the “amyloid hypothesis”—the idea that removing amyloid-beta (Aβ) plaques from the brain would stop or reverse Alzheimer’s disease. Recent data shows a complex reality: while monoclonal antibodies (mAbs) are highly effective at clearing these plaques, the clinical results are a … Read more

Early genomic testing prevents years of inconclusive visits for pediatric patients

by

The Shift Toward Whole Genome Sequencing as the Gold Standard The landscape of pediatric genomics is moving rapidly. While trio-based exome sequencing served as the entry-level testing for years, the future of rare disease diagnosis is shifting toward trio whole genome sequencing (WGS). This transition allows clinicians to capture a more complete picture of a … Read more

APC-deficient cancer cells rely on single enzyme for survival

by

The Shift Toward Metabolic Vulnerabilities in Cancer Care For years, treating colorectal cancer has often felt like a battle against a moving target. One of the most frequent culprits is the mutation of the APC gene. While these mutations are a defining characteristic of many colorectal tumors, they have remained notoriously difficult for scientists to … Read more

Targeting glutamine metabolism enhances CAR-macrophage cancer therapy

by

The New Frontier of Immunotherapy: Fueling the Fight Against Solid Tumors For years, the promise of CAR-T cell therapy has transformed the treatment of blood cancers. Still, solid tumors have remained a stubborn fortress, protected by a hostile tumor microenvironment (TME) that effectively starves and exhausts immune cells. The latest breakthrough in metabolic engineering is … Read more

Gut microbiome analysis may help detect Parkinson’s before symptoms appear

by

The Gut-Brain Axis: The Next Frontier in Parkinson’s Prevention For decades, we viewed Parkinson’s disease as a tragedy that began and ended in the brain. We focused on dopamine-producing neurons in the substantia nigra, treating the symptoms as they appeared—tremors, rigidity, and slowed movement. But the scientific narrative is shifting. The real story might actually … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]